(Q37086267)

English

Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation

scientific article published on 29 February 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

author name string

Biming He

1

1 reference

Europe PubMed Central

18 August 2017

Rui Chen

2

1 reference

Europe PubMed Central

18 August 2017

Xu Gao

3

1 reference

Europe PubMed Central

18 August 2017

Shancheng Ren

4

1 reference

Europe PubMed Central

18 August 2017

Bo Yang

5

1 reference

Europe PubMed Central

18 August 2017

Jianguo Hou

6

1 reference

Europe PubMed Central

18 August 2017

Linhui Wang

7

1 reference

Europe PubMed Central

18 August 2017

Qing Yang

8

1 reference

Europe PubMed Central

18 August 2017

Tie Zhou

9

1 reference

Europe PubMed Central

18 August 2017

Lin Zhao

10

1 reference

Europe PubMed Central

18 August 2017

Chuanliang Xu

11

1 reference

Europe PubMed Central

18 August 2017

Yinghao Sun

12

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

29 February 2016

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

7

1 reference

Europe PubMed Central

18 August 2017

13

1 reference

Europe PubMed Central

18 August 2017

17275-17285

1 reference

Europe PubMed Central

18 August 2017

Prostate cancer in Asian men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Is small prostate volume a predictor of Gleason score upgrading after radical prostatectomy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Smaller prostate gland size and older age predict Gleason score upgrading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Development and External Validation of a Nomogram Predicting the Probability of Significant Gleason Sum Upgrading among Japanese Patients with Localized Prostate Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Predicting 15-year prostate cancer specific mortality after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Decision curve analysis: a novel method for evaluating prediction models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

29 September 2017

Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

3 September 2018

Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

3 September 2018

Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

3 September 2018

The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

3 September 2018

External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

3 September 2018

Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

3 September 2018

Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4941387

4 December 2018

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26943768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

1 reference

https://pubmed.ncbi.nlm.nih.gov/26943768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series

1 reference

https://pubmed.ncbi.nlm.nih.gov/26943768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/26943768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer in Asia: A collaborative report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26943768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.7787

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37086267&oldid=2117989305"